D B McCoy1, J F Talbott1,2, Michael Wilson3, M D Mamlouk1, J Cohen-Adad4,5, Mark Wilson1, J Narvid6. 1. From the Department of Radiology and Biomedical Imaging (D.B.M., J.F.T., M.D.M., Mark Wilson, J.N.), University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California. 2. Brain and Spinal Injury Center (J.F.T.), Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California. 3. Department of Neurology (Michael Wilson), University of California, San Francisco. 4. Institute of Biomedical Engineering (J.C.-A.), Ecole Polytechnique Montreal, Montreal, Quebec, Canada. 5. Functional Neuroimaging Unit (J.C.-A.), CRIUGM, University of Montreal, Montreal, Quebec, Canada. 6. From the Department of Radiology and Biomedical Imaging (D.B.M., J.F.T., M.D.M., Mark Wilson, J.N.), University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California jared.narvid@ucsf.edu.
Abstract
BACKGROUND AND PURPOSE: Recent advances in spinal cord imaging analysis have led to the development of a robust anatomic template and atlas incorporated into an open-source platform referred to as the Spinal Cord Toolbox. Using the Spinal Cord Toolbox, we sought to correlate measures of GM, WM, and cross-sectional area pathology on T2 MR imaging with motor disability in patients with acute flaccid myelitis. MATERIALS AND METHODS: Spinal cord imaging for 9 patients with acute flaccid myelitis was analyzed by using the Spinal Cord Toolbox. A semiautomated pipeline using the Spinal Cord Toolbox measured lesion involvement in GM, WM, and total spinal cord cross-sectional area. Proportions of GM, WM, and cross-sectional area affected by T2 hyperintensity were calculated across 3 ROIs: 1) center axial section of lesion; 2) full lesion segment; and 3) full cord atlas volume. Spearman rank order correlation was calculated to compare MR metrics with clinical measures of disability. RESULTS: Proportion of GM metrics at the center axial section significantly correlated with measures of motor impairment upon admission (r [9] = -0.78; P = .014) and at 3-month follow-up (r [9] = -0.66; P = .05). Further, proportion of GM extracted across the full lesion segment significantly correlated with initial motor impairment (r [9] = -0.74, P = .024). No significant correlation was found for proportion of WM or proportion of cross-sectional area with clinical disability. CONCLUSIONS: Atlas-based measures of proportion of GM T2 signal abnormality measured on a single axial MR imaging section and across the full lesion segment correlate with motor impairment and outcome in patients with acute flaccid myelitis. This is the first atlas-based study to correlate clinical outcomes with segmented measures of T2 signal abnormality in the spinal cord.
BACKGROUND AND PURPOSE: Recent advances in spinal cord imaging analysis have led to the development of a robust anatomic template and atlas incorporated into an open-source platform referred to as the Spinal Cord Toolbox. Using the Spinal Cord Toolbox, we sought to correlate measures of GM, WM, and cross-sectional area pathology on T2 MR imaging with motor disability in patients with acute flaccid myelitis. MATERIALS AND METHODS: Spinal cord imaging for 9 patients with acute flaccid myelitis was analyzed by using the Spinal Cord Toolbox. A semiautomated pipeline using the Spinal Cord Toolbox measured lesion involvement in GM, WM, and total spinal cord cross-sectional area. Proportions of GM, WM, and cross-sectional area affected by T2 hyperintensity were calculated across 3 ROIs: 1) center axial section of lesion; 2) full lesion segment; and 3) full cord atlas volume. Spearman rank order correlation was calculated to compare MR metrics with clinical measures of disability. RESULTS: Proportion of GM metrics at the center axial section significantly correlated with measures of motor impairment upon admission (r [9] = -0.78; P = .014) and at 3-month follow-up (r [9] = -0.66; P = .05). Further, proportion of GM extracted across the full lesion segment significantly correlated with initial motor impairment (r [9] = -0.74, P = .024). No significant correlation was found for proportion of WM or proportion of cross-sectional area with clinical disability. CONCLUSIONS: Atlas-based measures of proportion of GM T2 signal abnormality measured on a single axial MR imaging section and across the full lesion segment correlate with motor impairment and outcome in patients with acute flaccid myelitis. This is the first atlas-based study to correlate clinical outcomes with segmented measures of T2 signal abnormality in the spinal cord.
Authors: Kevin Messacar; Teri L Schreiner; John A Maloney; Adam Wallace; Jan Ludke; M Stephen Oberste; W Allan Nix; Christine C Robinson; Mary P Glodé; Mark J Abzug; Samuel R Dominguez Journal: Lancet Date: 2015-01-29 Impact factor: 79.321
Authors: Philipp Hendrix; Christoph J Griessenauer; Julien Cohen-Adad; Shanmuganathan Rajasekaran; Keith A Cauley; Mohammadali M Shoja; Parham Pezeshk; R Shane Tubbs Journal: Clin Anat Date: 2014-02-04 Impact factor: 2.414
Authors: Peter J Dyck; Christopher J Boes; Donald Mulder; Clark Millikan; Anthony J Windebank; P James B Dyck; Raul Espinosa Journal: J Peripher Nerv Syst Date: 2005-06 Impact factor: 3.494
Authors: Regina Schlaeger; Nico Papinutto; Alyssa H Zhu; Iryna V Lobach; Carolyn J Bevan; Monica Bucci; Antonella Castellano; Jeffrey M Gelfand; Jennifer S Graves; Ari J Green; Kesshi M Jordan; Anisha Keshavan; Valentina Panara; William A Stern; H-Christian von Büdingen; Emmanuelle Waubant; Douglas S Goodin; Bruce A C Cree; Stephen L Hauser; Roland G Henry Journal: JAMA Neurol Date: 2015-08 Impact factor: 18.302
Authors: Marios C Yiannakas; Ahmed M Mustafa; Benjamin De Leener; Hugh Kearney; Carmen Tur; Daniel R Altmann; Floriana De Angelis; Domenico Plantone; Olga Ciccarelli; David H Miller; Julien Cohen-Adad; Claudia A M Gandini Wheeler-Kingshott Journal: Neuroimage Clin Date: 2015-11-10 Impact factor: 4.881
Authors: D B McCoy; S M Dupont; C Gros; J Cohen-Adad; R J Huie; A Ferguson; X Duong-Fernandez; L H Thomas; V Singh; J Narvid; L Pascual; N Kyritsis; M S Beattie; J C Bresnahan; S Dhall; W Whetstone; J F Talbott Journal: AJNR Am J Neuroradiol Date: 2019-03-28 Impact factor: 3.825
Authors: Olwen C Murphy; Kevin Messacar; Leslie Benson; Riley Bove; Jessica L Carpenter; Thomas Crawford; Janet Dean; Roberta DeBiasi; Jay Desai; Matthew J Elrick; Raquel Farias-Moeller; Grace Y Gombolay; Benjamin Greenberg; Matthew Harmelink; Sue Hong; Sarah E Hopkins; Joyce Oleszek; Catherine Otten; Cristina L Sadowsky; Teri L Schreiner; Kiran T Thakur; Keith Van Haren; Carolina M Carballo; Pin Fee Chong; Amary Fall; Vykuntaraju K Gowda; Jelte Helfferich; Ryutaro Kira; Ming Lim; Eduardo L Lopez; Elizabeth M Wells; E Ann Yeh; Carlos A Pardo Journal: Lancet Date: 2020-12-23 Impact factor: 79.321
Authors: Andrew C Smith; Denise R O'Dell; Stephanie R Albin; Jeffrey C Berliner; David Dungan; Eli Robinson; James M Elliott; Julio Carballido-Gamio; Jennifer Stevens-Lapsley; Kenneth A Weber Journal: Arch Phys Med Rehabil Date: 2021-08-08 Impact factor: 3.966
Authors: Enrico Rejc; Andrew C Smith; Kenneth A Weber; Beatrice Ugiliweneza; Robert J Bert; Mohammadjavad Negahdar; Maxwell Boakye; Susan J Harkema; Claudia A Angeli Journal: Front Syst Neurosci Date: 2020-10-21